Criteria | Treatmentb | SEMc | P-valued | |||||
---|---|---|---|---|---|---|---|---|
PC | SBP3 | SBP6 | SBP9 | SBP12 | Lin. | Quad. | ||
Body weight, kg | ||||||||
Initial | 9.01 | 9.01 | 9.01 | 9.01 | 9.01 | 0.300 | - | - |
2Â week | 12.83 | 12.15 | 12.48 | 12.63 | 12.32 | 0.380 | 0.68 | 0.86 |
5Â week | 20.79 | 19.77 | 21.21 | 22.67 | 21.23 | 0.625 | 0.16 | 0.47 |
ADG, g | ||||||||
0–2 week | 273 | 229 | 248 | 259 | 235 | 11.7 | 0.80 | 0.83 |
3–5 week | 379 | 370 | 393 | 478 | 424 | 18.9 | 0.20 | 0.29 |
0–5 week | 337 | 314 | 336 | 390 | 349 | 14.8 | 0.28 | 0.37 |
ADFI, g | ||||||||
0–2 week | 352 | 308 | 345 | 332 | 293 | 10.2 | 0.45 | 0.73 |
3–5 week | 821 | 761 | 857 | 853 | 747 | 22.1 | 0.83 | 0.99 |
0–5 week | 634 | 577 | 653 | 645 | 566 | 16.3 | 0.76 | 0.93 |
G:F ratio | ||||||||
0–2 week | 0.78 | 0.73 | 0.73 | 0.80 | 0.81 | 0.025 | 0.17 | 0.52 |
3–5 week | 0.57 | 0.59 | 0.64 | 0.71 | 0.65 | 0.033 | 0.42 | 0.60 |
0–5 week | 0.68 | 0.68 | 0.75 | 0.81 | 0.72 | 0.035 | 0.58 | 0.69 |